Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (US20170316169) Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions

Office : United States of America
Application Number: 15645062 Application Date: 10.07.2017
Publication Number: 20170316169 Publication Date: 02.11.2017
Grant Number: 10290374 Grant Date: 14.05.2019
Publication Kind : B2
IPC:
G01N 33/48
G16H 50/20
G06F 19/00
G16B 35/00
G16B 40/00
G16B 50/00
G16C 20/60
G06G 7/58
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
[IPC code unknown for G16H 50/20]
G PHYSICS
06
COMPUTING; CALCULATING; COUNTING
F
ELECTRIC DIGITAL DATA PROCESSING
19
Digital computing or data processing equipment or methods, specially adapted for specific applications
[IPC code unknown for G16B 35][IPC code unknown for G16B 40][IPC code unknown for G16B 50][IPC code unknown for G16C 20/60]
G PHYSICS
06
COMPUTING; CALCULATING; COUNTING
G
ANALOGUE COMPUTERS
7
Devices in which the computing operation is performed by varying electric or magnetic quantities
48
Analogue computers for specific processes, systems, or devices, e.g. simulators
58
for chemical processes
CPC:
G06F 19/00
G06F 19/3418
G16B 35/00
G16B 40/00
G16B 50/00
G16C 20/60
G16H 50/20
Y02A 90/26
Applicants: uBiome, Inc.
Inventors: Zachary Apte
Jessica Richman
Daniel Almonacid
Agents: Kilpatrick Townsend & Stockton LLP
Priority Data:
Title: (EN) Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Abstract: front page image
(EN)

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.